A Study of LY2181308 in Patients With Advanced Hepatocellular Carcinoma

NCT00415155 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
WITHDRAWN
Status
60
Enrollment
INDUSTRY
Sponsor class

Stopped Trial cancelled

Conditions

Interventions

Sponsor

Eli Lilly and Company